Purpose

The goal of this clinical trial is to test the extent to which different treatment components work to improve pediatric post-traumatic stress disorder (PTSD). It will also provide evidence for how these components work. The main research questions are: What are the effects of different components used to treat PTSD? What do these components change to produce benefits in PTSD? Researchers will: Compare components to a psychological placebo to estimate their effects and measure how they work Examine how components work alone and in conjunction with other components Participants will: Receive different combinations of components and placebo Attend weekly treatment sessions Provide information to evaluate changes in PTSD

Conditions

Eligibility

Eligible Ages
Between 8 Years and 17 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

A child between the ages of 8-17 exposed to at least one DSM-defined trauma Child assent for participation The participation of a caregiver with custodial rights to provide parental permission Willing to participate in treatment delivery and respond to surveys Meet PTSD diagnostic criteria that is the result of exposure to at least one of the identified traumas Ability to read and understand English Willingness to be randomized to an experimental condition Placement in a stable caregiving environment for two months without an impending transition Children currently taking psychotropic medications must have taken the medicine without dose adjustment for two months prior to study entry. Caregiver or child with a smartphone capable of downloading a freely available software application.

Exclusion Criteria

Psychiatric concerns requiring a higher level of care (e.g. suicidal ideation with intent; current psychotic disorder) An intelligence quotient (IQ) < 70 Currently receiving a behavioral health intervention for concerns related to PTSD or pediatric trauma A participating caregiver who is a perpetrator of any identified trauma (e.g. sexual abuse) MRI contraindicators (e.g. presence of metal in the body)

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial Assignment
Intervention Model Description
2^4 Full Factorial Randomized Clinical Trial
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Masking Description
Independent and masked raters of treatment fidelity; Independent and masked raters of processes of change during active treatment

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Treatment Condition 1
Participants receive emotion regulation, exposure, cognitive processing, and bi-lateral stimulation
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
Experimental
Treatment Condition 2
Participants receive emotion regulation, exposure, cognitive processing, and psychological placebo
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 3
Participants receive emotion regulation, exposure, bi-lateral stimulation, and psychological placebo
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 4
Participants receive emotion regulation, exposure, and psychological placebo
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 5
Participants receive emotion regulation, cognitive processing, bi-lateral stimulation, and psychological placebo
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 6
Participants receive emotion regulation, cognitive processing, and psychological placebo
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 7
Participants receive emotion regulation, bi-lateral stimulation, and psychological placebo
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 8
Participants receive emotion regulation and psychological placebo
  • Behavioral: Emotion Regulation
    Participants learn to reduce acute subjective distress, stabilize negative mood, promote positive mood, and alter physiological responses to trauma
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 9
Participants receive exposure, cognitive processing, bi-lateral stimulation, and psychological placebo
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 10
Participants receive exposure, cognitive processing, and psychological placebo
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 11
Participants receive exposure, bi-lateral stimulation, and psychological placebo
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 12
Participants receive exposure and psychological placebo
  • Behavioral: Exposure
    Participants engage in written exercises to reduce avoidance of trauma reminders and reinforce approach behaviors consistent with personal goals
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 13
Participants receive cognitive processing, bi-lateral stimulation, and psychological placebo
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 14
Participants receive cognitive processing and psychological placebo
  • Behavioral: Cognitive Processing
    Participants learn ways to identify, challenge, and overcome the influence of cognitive distortions resulting from trauma exposure
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 15
Participants receive bi-lateral stimulation and psychological placebo
  • Behavioral: Bi-lateral Stimulation
    Participants engage in horizontal eye movements while recalling a traumatic memory and describing their affective and physiological state
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure
Experimental
Treatment Condition 16
Participants receive psychological placebo
  • Behavioral: Psychological Placebo
    Participants receive non-directive support therapy, where they will guide the treatment session but not be required to discuss prior trauma exposure

Recruiting Locations

More Details

Status
Recruiting
Sponsor
University of Rochester

Study Contact

Chad E Shenk, PhD
(585) 275-8704
chad.shenk@rochester.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.